nach oben

Erschienen in:

01.07.2015 | Original Article - Services Research

Labour force participation and the influence of having arthritis on financial status

verfasst von: Deborah J. Schofield, Emily J. Callander, Rupendra N. Shrestha, Richard Percival, Simon J. Kelly, Megan E. Passey

Erschienen in: Rheumatology International | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study was to quantify the impact that having arthritis has on income poverty status and accumulated wealth in Australia. Cross-sectional analysis of Health&WealthMOD, a microsimulation model built on data from the Australian Bureau of Statistics’ Survey of Disability, Ageing and Carers and STINMOD, an income and savings microsimulation model. Across all categories of labour force participation status (employed full time, part time or not in the labour force at all), those with arthritis were significantly more likely to be in poverty. Those employed full time with no health condition had 0.82 times the odds of being in income poverty (95 % CI 0.80–0.84) compared with those employed full time with arthritis. Those not in the labour force with no chronic health conditions had 0.36 times the odds of being in income poverty compared with those not in the labour force due to arthritis (95 % CI 0.36–0.37). For people not in the labour force with no long-term health condition, the total value of their wealth was 211 % higher (95 % CI 38–618 %) than the amount of wealth accumulated by those not in the labour force due to arthritis. Similarly, those employed part time with no chronic health condition had 50 % more wealth than those employed part time with arthritis (95 % CI 3–116 %). Arthritis has a profound impact upon the economic circumstances of individuals, which adds a further dimension to the detrimental living standards of older individuals suffering from the condition.

The income unit is defined by the ABS as ‘a group of two or more related persons in the same household assumed to pool their income and savings and share the benefits deriving from them equitably, or one person assumed to have sole command over his or her income, consumption and savings’ [23].

Calculated for persons with wealth, some accumulated wealth, excluding those with zero wealth.

Yelin E, Cisternas M, Foreman A, Pasta D, Murphy L, Helmick C (2007) National and state medical expenditures and lost earnings attributable to arthritis and other rheumatic conditions—United States, 2003. Morb Mortal Wkly Rep 56:4–7

Australian Institute of Health and Welfare (2008) Australia’s health 2008. AIHW, Canberra

Cooper NJ (2000) Economic burden of rheumatoid arthritis: a systematic review. Rheumatology 39(1):28–33CrossRefPubMed

Li X, Gignac M, Anis A (2006) The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work. Med Care 44(4):304CrossRefPubMed

Economics Access (2005) The economic cost of arthritis in New Zealand. Arthritis, New Zealand

Access Economics (2007) Painful realities: the economic impact of arthritis in Australia in 2007. Arthritis, Forest Lodge

Dunlop D, Manheim L, Yelin E, Song J, Chang R (2003) The costs of arthritis. Arthritis Rheum 49(1):101–113CrossRefPubMed

Gignac M, Cao X, Lacaille D, Anis A, Badley EM (2008) Arthritis-related work transitions: a prospective analysis of reported productivity losses, work changes, and leaving the labor force. Arthritis Rheum (Arthritis Care Res) 59(12):1805–1813CrossRef

Verstappen SMM, Boonen A, Bijlsma JWJ, Buskens E, Verkleij H, Schenk Y, van Albada-Kuipers GA, Hofman DM, Jacobson JWG (2004) Working status among Dutch patients with rheumatoid arthritis: work disability and working conditions. Rheumatology 44(2):202–206CrossRefPubMed

10.

Burton W, Morrison A, Maclean R, Ruderman E (2006) Systematic review of studies of productivity loss due to rheumatoid arthritis. Occup Med 56(1):18–27CrossRef

11.

Badley EM, Wang PP (2001) The contribution of arthritis and arthritis disability to nonparticipation in the labor force: a Canadian example. J Rheumatol 28(5):1077–1082PubMed

12.

Schofield DJ, Shrestha RN, Passey ME, Earnest A, Fletcher SL (2008) Chronic disease and labour force participation among older Australians. Med J Aust 189(8):447PubMed

13.

Australian Bureau of Statistics (2006) National health survey 2004–2005: summary of results. Australian Bureau of Statistics, Canberra

14.

Wolfe F, Michaud K, Williams R (2005) Household income and earnings losses among 6,396 persons with rheumatoid arthritis. J Rheumatol 32(10):1875–1883PubMed

15.

Schofield D, Shrestha R, Percival R, Passey M, Kelly S, Callander E. Economic impacts of illness in older workers: quantifying the impact of illness on income, tax revenue and government spending. BMC Pub Health 11(418). doi:10.1186/1471-2458-11-418

16.

Albers JM, Kuper HH, van Riel PL, Prevoo ML, van ’t Hof MA, van Gestel AM, Severens JL (1999) Socio-economic consequences of rheumatoid arthritis in the first years of the disease. Rheumatology 38(5):423–430CrossRefPubMed

17.

Hagenaars A, de Vos K (1988) The definition and measurement of poverty. J Hum Resour 23(2):211–221CrossRef

18.

Harding A, Lloyd R, Greenwell H (2001) Financial disadvantage in Australian 1990–2000: the persistence of poverty in a decade of growth. The Smith Family, Camperdown

19.

Miles D (1999) Modelling the impact of demographic change upon the economy. Econ J 109:1–36CrossRef

20.

Bloom DE, Canning D, Graham B (2003) Longevity and life-cycle savings. Scand J Econ 105(3):319–338CrossRef

21.

Sala-i-Martín X (2005) On the health poverty trap. In: Lopez-Casasnovas G, Currais L (eds) Health and economic growth: findings and policy implications. The MIT Press, Cambridge

22.

Zhang J, Zhang J (2005) The effect of life expectancy on fertility, saving, schooling and economic growth: theory and evidence. Scand J Econ 107(1):45–66CrossRef

23.

Australian Bureau of Statistics (2005) Information paper—basic confidentialised unit record file: survey of disability, ageing and carers 2003 (reissue). Australian Bureau of Statistics, Canberra

24.

Percival R, Abello A, Vu QN (2007) STINMOD (static income model) 2007. In: Gupta A, Harding A (eds) Modelling our future: population ageing, health and aged care. Elsevier, Amsterdam

25.

World Health Organisation (2010) International classification of diseases (ICD) [cited 6 Oct 2010]. Available from: http://apps.who.int/classifications/apps/icd/icd10online/

26.

Schofield D, Shrestha R, Percival R, Kelly S, Passey M, Callander E, Fletcher S. Modelling the cost of ill health in Health&WealthMOD: lost labour force participation, income and taxation, and the impact of disease prevention (under review)

27.

De Vos K, Zaidi MA (1997) Equivalence scale sensitivity of poverty statistics for the member states of the European community. Rev Income Wealth 43(3):319–333CrossRef

28.

Saunders P (1996) Poverty, income distribution and health: an Australian study. In: SPRC reports and proceedings. Social Policy Research Centre, Sydney

29.

Saunders P, Bradbury B (2006) Monitoring trends in poverty and income distribution: data, methodology and measurement. Econ Rec 82(258):341–364CrossRef

30.

Saunders P, Hill T, Bradbury B (2007) Poverty in Australia: sensitivity analysis and recent trends 2007 SPRC. University of New South Wales, Sydney

31.

Mejer L, Siermann C (2000) Income poverty in the European Union: children, gender and poverty gaps. In: Statistics in focus: population and social conditions. Eurostat

32.

Trigger D (2003) Does the way we measure poverty matter? In: Discussion paper no. 59, NATSEM, Canberra

33.

Hagenaars A, de Vos K, Zaidi MA (1994) Poverty statistics in the late 1980s: research based on micro-data. Office for Official Publications of the European Communities, Luxembourg

34.

Kelly S (2009) Don’t stop thinking about tomorrow—the changing face of retirement—the past, the present and the future. In: AMP.NATSEM income and wealth report (issue 24), AMP, Sydney

35.

Schofield D, Kelly S, Shrestha R, Callander E, Passey M, Percival R (2010) Long term financial impacts of CVD: living standards in retirement. Int J Cardiol (in press). Available online: http://dx.doi.org/10.1016/j.ijcard.2010.10.046

36.

Schofield D, Passey M, Percival R, Shrestha R, Callander E, Kelly S (2011) Retiring early with cardiovascular disease—impact on individual’s financial assets. Int J Cardiol 146(1):125–126CrossRefPubMed

37.

Schofield D, Percival R, Passey M, Shrestha R, Callander E, Kelly S (2011) The financial vulnerability of individuals with diabetes. Br J Diabetes Vasc Dis 10(6):300–304CrossRef

38.

Swoboda SM, Lipsett PA (2002) Impact of a prolonged surgical critical illness on patients’ families. Am J Crit Care 11(5):459–466PubMed

39.

Mills A, Shillcutt S (2004) Communicable diseases. In: Lomborg B (ed) Global crises, global solutions. Cambridge University Press, Cambridge

40.

Productivity Commission (2005) Economic implications of an ageing Australia. In: Research Report Productivity Commission, Canberra. Australian Government, Canberra

41.

Mau W, Bornmann M, Weber H, Weidemann HF, Hecker H, Raspe HH (1996) Prediction of permanent work disability in a follow-up study of early rheumatoid arthritis: results of a tree structured analysis using RECPAM. Br J Rheumatol 35:652–659CrossRefPubMed

42.

Lacaille D, Sheps S, Spinelli JJ, Chalmers A, Esdaile JM (2004) Identification of modifiable work-related factors that influence the risk of work disability in rheumatoid arthritis. Arthritis Rheum 51(5):843–852CrossRefPubMed

43.

Wolfe F, Hawley DJ (1998) The long term outcomes of rheumatoid arthritis: work disability—a prospective 18-year study of 823 patients. J Rheumatol 25(11):2108–2117PubMed

44.

Yelin E, Katz P, Lubeck D, Wanke L, Buatti M (2001) Impact of etanercept (Enbrel^®) on health care use and employment in early RA. Arthritis Rheum 44(Supplement 9):152

45.

Puolakka K, Kautiainen H, Mottonen T, Hannonen P, Korpela M, Julkunen H, Luukkainen R, Vuori K, Paimela L, Blafield H, Hakala M, Leirisalo-Repo M (2004) Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a 5-year randomized followup trial. Arthritis Rheum 50(1):55–62CrossRefPubMed

Titel: Labour force participation and the influence of having arthritis on financial status
verfasst von: Deborah J. Schofield
Emily J. Callander
Rupendra N. Shrestha
Richard Percival
Simon J. Kelly
Megan E. Passey
Publikationsdatum: 01.07.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Rheumatology International / Ausgabe 7/2015
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-015-3224-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Labour force participation and the influence of having arthritis on financial status

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2015

Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis

The clinical usefulness of ESR, CRP, and disease duration in ankylosing spondylitis: the product of these acute-phase reactants and disease duration is associated with patient’s poor physical mobility

The association between comorbidities and pain, physical function and quality of life following hip and knee arthroplasty

The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients

Dose modifications of anti-TNF drugs in rheumatoid arthritis patients under real-world settings: a systematic review

Diastolic dysfunction and endothelial dysfunction in systemic lupus erythematosus

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin